The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

Doctors say there's no reason to believe the new variant will cause any more severe illness than previous mutations of the ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Since regaining power in January, the Trump administration has repeatedly claimed with false certainty that the COVID-19 ...

Multiple Covid-19 cases have been reported in Delhi, Karnataka, Maharashtra, Andhra Pradesh, among other places, in the last ...

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.

In India, the most common variant remains JN.1, comprising 53% of samples tested, followed by BA.2 (26%) and other Omicron ...